EUVIMEDEUVIMED entdecken
Crossref

Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12‐year retrospective analysis within NETwerk , an ENETS center of excellence

Laura Mariën iD, Siddharth Chhajlani iD, Carlien De Herdt iD, Kobe Ceulemans, Silke Van Hoegaerden, Morgane Leuridan, Nathalie Van Daele, Pascale Abrams, Wim Demey iD, Marijke Ulenaers, Willem Lybaert, Katleen Janssens iD und 1 weitere

Journal of Neuroendocrinology · 2026-05 · 38 (5)

DOI: 10.1111/jne.70193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 15.05.2026. Verfasst von Laura Mariën und 12 weiteren Autor:innen. Beteiligte Einrichtung: MedGen Group, Center of Medical Genetics, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Germ-Line Mutation, Genetic Testing. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant tumor predisposition syndrome in which neuroendocrine tumors (NET) represent a major driver of morbidity and mortality. Timely recognition of MEN1 after NET diagnosis enables syndrome‐specific surveillance and cascade testing, yet real‐world evidence on MEN1 testing implementation in oncology pathways remains limited. The aim of this study was to evaluate MEN1 testing practices and assess concordance with guideline‐based indications and nomogram‐predicted risk. A retrospective cohort study was performed within NETwerk, a Belgian ENETS CoE, with patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsMultiple Endocrine Neoplasia Type 1Germ-Line MutationGenetic TestingProto-Oncogene ProteinsHumansRetrospective StudiesMaleMiddle AgedFemaleAdultAgedBelgium

Stichwörter der Autor:innen

MEN1NETgermline testingnomogram

Substanzen

MEN1 protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • MedGen Group, Center of Medical Genetics, University of Antwerp, Antwerp, Belgium.
  • NETwerk-ENETS Center of Excellence, Antwerp-Waasland, Belgium.
  • Department of Oncology, Antwerp University Hospital, Antwerp, Belgium.
  • Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Department of Endocrinology, Antwerp University Hospital, Antwerp, Belgium.
  • Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Laura Mariën, Siddharth Chhajlani, Carlien De Herdt, Wim Demey, Katleen Janssens, Timon Vandamme

Förderung

  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Mariën, L., Chhajlani, S., De Herdt, C., Ceulemans, K., Van Hoegaerden, S., Leuridan, M., Van Daele, N., Abrams, P., Demey, W., Ulenaers, M., Lybaert, W., Janssens, K., & Vandamme, T. (2026). Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12‐year retrospective analysis within NETwerk , an ENETS center of excellence. Journal of Neuroendocrinology, 38(5). https://doi.org/10.1111/jne.70193

Vancouver

Mariën L, Chhajlani S, De Herdt C, Ceulemans K, Van Hoegaerden S, Leuridan M, et al. Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12‐year retrospective analysis within NETwerk , an ENETS center of excellence. Journal of Neuroendocrinology. 2026;38(5). doi:10.1111/jne.70193

BibTeX
@article{Marin2026,
  author = {Mariën, Laura and Chhajlani, Siddharth and De Herdt, Carlien and Ceulemans, Kobe and Van Hoegaerden, Silke and Leuridan, Morgane and Van Daele, Nathalie and Abrams, Pascale and Demey, Wim and Ulenaers, Marijke and Lybaert, Willem and Janssens, Katleen and Vandamme, Timon},
  title = {Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12‐year retrospective analysis within NETwerk , an ENETS center of excellence},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  volume = {38},
  number = {5},
  doi = {10.1111/jne.70193}
}
Kostenlos starten →